155 related articles for article (PubMed ID: 35045553)
1. Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography.
Güç ZG; Turgut B; Avci A; Cengiz F; Eren Kalender M; Alacacioğlu A
Nucl Med Commun; 2022 May; 43(5):560-567. PubMed ID: 35045553
[TBL] [Abstract][Full Text] [Related]
2.
Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J
Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
[No Abstract] [Full Text] [Related]
3. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline
Garcia-Vicente AM; Pérez-Beteta J; Amo-Salas M; Molina D; Jimenez-Londoño GA; Soriano-Castrejón AM; Pena Pardo FJ; Martínez-González A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):73-79. PubMed ID: 29102649
[TBL] [Abstract][Full Text] [Related]
4. Volumetric parameters changes of sequential 18F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Kim SJ; Chang S
Clin Nucl Med; 2015 Dec; 40(12):930-5. PubMed ID: 26204222
[TBL] [Abstract][Full Text] [Related]
5. Early Metabolic Response Assessed Using 18F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer.
Kim N; Park W; Cho WK; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH; Lee YY; Cho YS
Cancer Res Treat; 2021 Jul; 53(3):803-812. PubMed ID: 33321566
[TBL] [Abstract][Full Text] [Related]
6. Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer.
Tamandl D; Gore RM; Fueger B; Kinsperger P; Hejna M; Paireder M; Haug A; Schoppmann SF; Ba-Ssalamah A
Eur Radiol; 2016 Feb; 26(2):311-21. PubMed ID: 26040648
[TBL] [Abstract][Full Text] [Related]
7. Intra-tumor metabolic heterogeneity of gastric cancer on
Liu G; Yin H; Cheng X; Wang Y; Hu Y; Liu T; Shi H
Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779
[TBL] [Abstract][Full Text] [Related]
8. [
Vos JL; Zuur CL; Smit LA; de Boer JP; Al-Mamgani A; van den Brekel MWM; Haanen JBAG; Vogel WV
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2010-2022. PubMed ID: 34957526
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of mid-radiotherapy
Kim N; Cho H; Yun M; Park KR; Lee CG
Radiat Oncol; 2019 Feb; 14(1):27. PubMed ID: 30717809
[TBL] [Abstract][Full Text] [Related]
10. The role of
Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of the Volumetric Parameters of Dual-Time-Point
Okazaki E; Seura H; Hasegawa Y; Okamura T; Fukuda H
AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426
[No Abstract] [Full Text] [Related]
12. The role of basal metabolic and volumetric
Kepenek F; Karaoğlan H; Can C; Kömek H; Kaplan İ; Etem H; Ebinç S; Kavak Ş; Gündoğan C
Hell J Nucl Med; 2022; 25(3):235-246. PubMed ID: 36507879
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of volume-based parameters using
Park JS; Lee N; Beom SH; Kim HS; Lee CK; Rha SY; Chung HC; Yun M; Cho A; Jung M
Gastric Cancer; 2018 Mar; 21(2):213-224. PubMed ID: 28643145
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of interim
Lee SY; Seo HJ; Kim S; Eo JS; Oh SC
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e302-e309. PubMed ID: 29226597
[TBL] [Abstract][Full Text] [Related]
15. [
Annovazzi A; Ferraresi V; Anelli V; Covello R; Vari S; Zoccali C; Biagini R; Sciuto R
Eur Radiol; 2021 Sep; 31(9):7012-7021. PubMed ID: 33715090
[TBL] [Abstract][Full Text] [Related]
16. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
17. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R
Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
[TBL] [Abstract][Full Text] [Related]
18.
Vallius T; Hynninen J; Kemppainen J; Alves V; Auranen K; Matomäki J; Oksa S; Virtanen J; Grénman S; Auranen A; Seppänen M
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1224-1232. PubMed ID: 29476227
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
20. Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer.
Sun G; Cheng C; Li X; Wang T; Yang J; Li D
Cancer Imaging; 2019 Mar; 19(1):18. PubMed ID: 30902116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]